Isolation Of Extended-Spectrum B-Lactamase (ESBL) Producing Escherichia coli and Klebsiella pneumiae From Dr. Zainoel Abidin General Hospital, Aceh

Zinatul Hayati, Syamsul Rizal, Ridhia Putri

Abstract


Infection that occurs in Indonesia has increased more significantly than before, compared to the increasing bacterial multidrug resistance (MDR) as the cause of infection. A study conducted in 5 hospitals in Indonesia in 2013 showed that the prevalence rate of extended-spectrum β-lactamase (ESBL)-producing bacteria reached 32-68%. The objective of this study is to detect the prevalence and resistence pattern of ESBL-producing Escherichia coli and Klebsiella pneumoniae in Dr. Zainoel Abidin General Hospital, Banda Aceh. This study was conducted from 1 September 2016 to 31 December 2016. Specimen types included in this study were blood, sputum, urine, pus, mucosal swab, and another body fluids sample. The sampling method in this study was total sampling that is all clinical specimen examined in Clinical Microbiology Laboratory. Isolation and identification ESBL-producing bacteria was performed by VITEK-2 machine (Biomerieux). The result of this study is that a total 122 E. coli and K. pneumoniae were isolated. That consisted of 48 (39%) E. coli isolates and 74 (61%) K. pneumoniae isolates. From 48 E. coli isolates it was found out that 41 (85%) had ESBL phenotypes and from 74 K. pneumoniae isolates it was found out that 59 (80%) had ESBL phenotypes. In total, 100 (82%) isolates from 122 isolates had ESBL phenotypes. Distribution of ESBL-producing E. coli and K. pneumoniae based on sample was 24 (89%) isolates from the total of 27 urine isolates, 18 (95%) isolates from the total of 19 blood isolates, 28 (78%) isolates from the total of 36 sputum isolates, and 30 (75%) isolates from the total of 40 pus isolates. Antibiotic sensitivity pattern of the E. coli and K. pneumoniae isolates had high sensitivity to amycasin dan meropenem which was above 89%. Meanwhile, it also had sensitivity to Fosfomycin and Piperacyclin-Tazobactam by 80% and 77% respectively. Another antibiotic was less effective

Full Text:

PDF

References


Ajao A.O., Johnson J.K., Harris A.D., Zhan M., McGregor J.C., Thom K.A., Furuno J.P. (2013). Risk of Acquiring Extended-Spectrum b-Lactamase–Producing Klebsiella Species and Escherichia coli from Prior Room Occupants in the Intensive Care Unit. Infection Control and Hospital Epidemiology, Vol.34, No.5: 453-458.

AMRIN Study. (2005). Antimicrobial resistance in Indonesia: Prevalence and prevention. The Collaboration research Indonesia and The Netherlands. Not yet published.

Arifin H., Navaratnam P., Kee T.K., Balan, G. (2004). Antibiotic Resistance Patterns in Nosocomial gram Negative Bacterial Infections in Unit with Heavy Antibiotic Usage. J. Trop. Pediatrics, Vol. 50 (No. 1):26-31.

Babini, G.S. and Livermore D.M. (2000). Antimicrobial resistance amongst Klebsiella spp collected from intensive care units in Southern and Western Europe in 1997-1998. J. Antimicrob. Chemother, 45: 182-189.

Bramantono, Purwati, Hamidah. (2013). The Prevalence of Extended Spectrum Beta-Lactamase (ESBL) In Third Generation Cephalosporin Usage Among Sepsis Patients In The Department of Internal Medicine Rsud Dr. Soetomo Surabaya. Folia Medica Indonesiana, Vol. 49 No. 4: 244-251.

Branger C., Lesimple A.L., Briuneu B., Berry P., Lambert-Zechovsky N. (1998). Long-term investigation of the clonal dissemination of Klebsiella pnaumoniae isolates producing extended-spectrum beta-lactamases in a university hospital. J. Med. Microbiol, 47: 201-209.

Bujdakova H., Lausova A., Jankovikova S., Prodinger W.M., Kallova J., Milosovic P., Kettner M. (1998). Study of beta lactam resistance in Ceftazidime resistant clinical isolates of Enterobacteriaceae. Intern. J. Antimicrob. Agents, 10: 135-141.

Bush K., Jacoby G.A., Medeiros A.A. (1995). A functional Classification Scheme for -lactamases and its Correlation with Molecular structure. Antimicrob. Agents Chemother, Vol. 39, No. 6: 1211-1233.

Chlebicki M.P., Oh H.M.L. (2004). Extended Spectrum Beta Lactamases in Clinical Isolates of Escherichia coli and Klebsiella spp. In a Singapore Hospital: Clinical Spectrum. Annals. Academy of Medicine, 3: 302-306.

CLSI (Clinical and Laboratory Standars Institute) (Formerly NCCLS). (2012). Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Information Supplement, M100-S15. Pennsylvania, USA: Clinical and Laboratory Standard Institute (CLSI)/NCCLS).

Daoud Z. Kahine N. (2003). Prevalence and Susceptibility Pattern of Extended Spectrum beta-Lactamases-Producing Escherichia coli and Klebsiella pneumoniae in a General University Hospital in Beirut, Lebanon. Rev. Esp. Quimiother, 16(2): 233-38.

Einhorn A.E., Neuhauser M.M., Bearden D.T., Quinn J.P., Pendland S.L., (2002). Extended Spectrum Beta-lactamases: Frequency, Risk Factor and Outcome. Pharmacotherapy (Medscape), 22(1): 14-20.

Fatmawati N.N.D., N.M.A. Tarini, N.N.S. Budayanti, and P. Yuliandari. (2015). Molecular Characterization of Extended-Spectrum-Lactamases-Producing Klebsiella pneumoniae Isolated from Clinical Specimens at a Tertiary-Referral Hospital in Denpasar, Bali, Indonesia. Bali: Advanced Science Letters. pp. 219–221.

Herwana E., Yenny, Pudjiadi L., Surjawidjajaand J.E., Lesmana M. (2008). Prevalence of extended spectrum beta-lactamase in Klebsiella pneumonia. Universa Medicina, 27(3): 98-105.

Jabeen K., Zafar A., Hasan R. (2005). Frequency and Sensitivity pattern of Extended Spectrum Beta Lactamase producing isolates in a tertiary care hospital laboratory of Pakistan. J. Pak. Med. Assoc, (Vol.55) 10:436-439.

Johnson D.M., Biedenbach D.J., Jones R.N. (1999). In vitro evaluation of Broad spectrum beta-lactams in the Philippines Medical Centers: Role of Fourth Generation Cephalosporin. Diagn. Microbiol. Infect. Dis, 35: 291-297.

Keiko F., Rosa Y. (2013). The incidence of Enterobacteriaceae producing Extended-Spectrum Beta-Lactamase (ESBL) and Its Relation to the Use of Tracheal Tube on the ICU Patients at the Cipto Mangunkusumo Central Hospital in 2011. Unpublished.

Kim Y.K., Pai H., Lee H.J., Park S.E., Choi E.H., Kim J., Kim J.H., and Kim E.C. (2002). Blood stream infection by Extended spectrum beta-lactamases Producing Escherichia coli and Klebsiella pneumoniae in Children: Epidemiology and Clinical outcome. Antimicrob. Agents Chemother, 46(5):1481-1491.

Kuntaman K., Santoso S., Wahjono H., Mertaniasih N.M., Lestari E.S., Farida H., Hapsari R., Firmanti S.C., Noorhamdani A.S., Santosaningsih D., Purwono P.B., Kusumaningrum D. (2011). The Sensitivity Pattern of Extended Spectrum Beta Lactamase-Producing Bacteria Against Six Antibiotics that Routinely Used in Clinical Setting. J Indon Med Assoc (Majalah Kedokteran Indonesia), Vol. 61 (12): 482-486.

Kuntaman K., Mertaniasih N.M., and Hadi U. (2006). Multiresistance Pattern of Extended Spectrum Β-Lactamase (ESBL) – Escherichia coli and Klebsiella pnemoniae Strains. Folia Medica Indonesiana, Vol. 42 No. 1: 40 – 46.

Kuntaman K., Hadi U. , Paraton H., Qibtiyah M., Wasito E.B., Koendhori E.B., Santosaningsih D., Erikawati D., Fatmawati N.N.D., Budayanti N.N.S., Priyambodo Y., Saptawati L., Mulyani U.A. (2013). The Surveillance of Klebsiella pneumoniae and Escherichia coli producing ESBL in Indonesia. Unpublished.

Kuntaman N., Rachman, Hardjowijoto S. (1996). The pattern of Antimicroba use in the ward of Urology Surgery at Dr. Soetomo Regional General Hospital Surabaya. Majalah Teknologi Kedokteran Indonesia, XI(1):6-12.

Lee K., Lim J.K., Yong D., Yum J., Chong Y., Okamoto R., and Inoue M. (2001). Evaluation of Efficiency of Screening Extended-Spectrum -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Hospitals Where the Bacteria Are Increasingly Prevalent. J. Clinic Microbiol, 39 (10): 3696-3699.

Livermore D.M. (1996). Are all beta lactams created equal ?. Scand. J. Infect. Dis, 101: 33-43.

Pajariu A., Firmanti S.C., Isbandrio B. (2010). The Infection caused by bacteria producing Extended-Spectrum Beta-Lactamase (ESBL) at Dr. Kariadi General Hospital Semarang: The Risk factor related to antibiotic use. Semarang: Program Pendidikan Sarjana Kedokteran Fakultas Kedokteran Universitas Diponegoro.

Palucha A., Mikiewicz B., Hryniewiez W., Gniadkowski M. (1999). Concurrent outbreaks of extended-spectrum -Lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw Hospital. J. Antimicrob. Chemo, 44: 489-499.

Paterson D.L., Ko W.L., Gottberg A.V., Casellas J.M., Mulazimoglu L., Klugman K.P., Bonomo R.A., Rice L.B., McCormack J.G., Yu V.L.. (2011). Outcome of cephalosporin treatment for serious infection due to apparently susceptible organism producing Extended spectrum -lactamases: Implication for the Clinical Microbiology Laboratory. J. Clin. Microb, Vol. 32, 6: 2206-2212.

Pena C., Pujol M., Ardanuy C., Ricart A., Pallares R., Linares J., Ariza J., Gudiol F. (1998). Epidemiology and successful Control of a large outbreak Due to Klebsiella pneumoniae Producing Extended spectrum beta-lactamases. Antimicrobial. Agents Chemother, Vol. 42, 1: 53-58.

Peterson D.L., Yu V.L. (1999). Extended spectrum beta lactamases a call for important detection and control. Clin. Infect. Dis, 29: 1419-1422.

Severin J.A., Lestari E.S., Kloezen W., Toom N.L., Mertaniasih N.M., Kuntaman K., Purwanta M., Duerink D.O., Hadi U., Belkum van A, Verbrugh H.A., Goessens W.H. (2012). Faecal carriage of extended-spectrum b-lactamase-producing Enterobacteriaceae among humans in Java, Indonesia, in 2001–2002. Tropical Medicine and International Health, Vol.17 4:455-461.

Severin J.A., Mertaniasih N.M., Kuntaman K., Lestari E.S., Purwanta M., Toom N.L., Duerink D.O., Hadi U., Belkum van A, Verbrugh H.A. and Goessens W.H. (2010). Molecular characterization of extended-spectrum b-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia. J Antimicrob Chemother, 65: 465–469.

Soegijanto S. (1998). Disease and the use of antibiotic pattern in Department of Child Health Dr. Soetomo Hospital Surabaya. Folia Medica Indonesiana, 3: 1-4.

Spanu T., Luzzaro F., Perilli M., Amilosante G., Toniolo A., Fadda G. (2002). The Italian ESBL Study Group. Occurrence of Extended Spectrum Beta-lactamases in Members of the Family Enterobacteriaceae in Italy: Implication for Resistance to Beta-lactam and other antimicrobial Drugs. Antimicrob. Agents Chemother, 46(1):196-202.

Stobberingh E.E., Arends J., Hoogkamp-Korstanje J.A., Goessens W.H., Visser M.R., Buiting A.G., Debets-Ossenkopp Y.J., Ketel van RJ, van Ogtrop M.L., Sabbe L.J., Voorn G.P., Winter H.L., van Zeijl J.H. (1999). Occurrence of Extended spectrum beta-lactamases in Dutch hospitals. Infection, 27(6): 348-354.

Villegas M.V., Correa A., Perez F., Miranda M.C., Zuluaga T., Quinn J.P. (2004). Prevalence and characterization of extended-spectrum -Lactamase in Klebsiella pneumoniae and Escherichia coli isolates from Colombia hospitals. Diagnos Microb, 49: 217-222.

Warganegara E., Apriliana E. (2014). The Determining type of Extended-Spectrum Β-Lactamase Enzyme (ESBL) from Escherichia coli resistance Cephalosporine of third Generation in RSUD Abdoel Moeloek Bandar Lampung. JUKE, Vol. 4 (7), 87-96.

Winarto. (2009). The Prevalences of Extended Spectrum Beta Lactamase (ESBL) germs from blood material at Dr. Kariadi General Hospital in 2004-2005. Media Medika Indonesiana, Vol.43, 5: 260-267.

Yuwono. (2011). The Prevalence of TEM Gens on Extended-Spectrum Beta-Lactamases Producing Enterobacteriaceae. J. Kedokteran dan Kesehatan, 1:3098-3102.




DOI: https://doi.org/10.21157/ijtvbr.v4i1.13806

Article Metrics

Abstract view : 0 times
PDF - 0 times

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

 Indexed in: 

Copyright© 2016 | ISSN: 2503-4715 


Published by: 
The Faculty of Veterinary Medicine of Syiah Kuala University
In cooperation with: 
Center for Tropical Veterinary Studies of Syiah Kuala University
and Indonesian Veterinary Medical Association (PDHI)

Online Submissions & Guidelines  | Editorial Policies  | Contact |  Statistics  


Creative Commons License
IJTVBR is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.